Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 6 months ago

Possible Interaction: Nitric Oxide and Glabridin

supplement:

Glabridin

Research Papers that Mention the Interaction

We observed that Glab significantly suppressed the levels of nitric oxide (NO), NF‐&kgr;B subunit p65, interleukin (IL)‐6, and IL‐1&bgr; in lipopolysaccharide (LPS)‐stimulated HaCaT cells.
International immunopharmacology  •  2018  |  View Paper
Increased levels of H2O2 and NO were observed in a dose-dependent manner after treatment of glabridin that further affected macromolecules such as DNA, lipids, and proteins.
Free radical biology & medicine  •  2015  |  View Paper
The levels of SPA, MDA and NO in lung were down-regulated significantly in groups administrated with GLA.
Oncotarget  •  2017  |  View Paper
Additionally, the nitric oxide level significantly increased upon glabridin pretreatment.
Journal of agricultural and food chemistry  •  2016  |  View Paper
Glabridin showed significant inhibition of NO and IL-1 beta release, but failed to attenuate IL-6 levels at the tested concentrations.
Inflammopharmacology  •  2011  |  View Paper
Collectively, these data suggest that glabridin inhibits NO production and iNOS gene expression by blocking NF-κB/Rel activation and that this effect was mediated, at least in part, by inhibiting reactive oxygen species generation.
Glabridin attenuated lipopolysaccharide (LPS)-induced NO production in isolated mouse peritoneal macrophages and RAW 264.7 cells, a mouse macrophage-like cell line.
In the present study, we report the inhibitory effect of glabridin on nitric oxide (NO) production and inducible nitric oxide (iNOS) gene expression in murine macrophages.
Journal of Pharmacology and Experimental Therapeutics  •  2005  |  View Paper
Moreover, glabridin (50microM) decreased the 10(-10)M TNF-alpha-induced production of PGE2 and NO in osteoblasts.
Biochemical pharmacology  •  2005  |  View Paper